Copertina

Effect of Camel Milk on the Spirometry Parameters of Children With Cystic Fibrosis: The First Double Blind Randomized Clinical Trial

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Seyed Javad Sayedi, Toktam Kheirabadi, Saeid Zibaee, Elham Bakhtiari
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Pulmonology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis
di: Aqeem Azam, et al.
Pubblicazione: (2025)

Randomized Cross‐Over Analysis of the Influence of Nitrogen Multiple Breath Washout on Spirometry in Monitoring Lung Function in Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia
di: Anna Charlotte Schoop, et al.
Pubblicazione: (2025)

“It's Like You're Feeding Your Child Twice”: Barriers and Facilitators to Human Milk Feeding Children With Cystic Fibrosis
di: Adrianne Colborg, et al.
Pubblicazione: (2025)

The CARMUCI Study Design: A Double‐Blind, Cross‐Over Sham‐Controlled Trial of Indoor Air Purification in People With Cystic Fibrosis and Primary Ciliary Dyskinesia
di: Maria G. Kakkoura, et al.
Pubblicazione: (2026)

“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
di: Tuğba Şişmanlar Eyüboğlu, et al.
Pubblicazione: (2026)

Effects of Elexacaftor‐Tezacaftor‐Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis
di: Guillaume Petit, et al.
Pubblicazione: (2025)

Establishment and Analysis of the First Electronic Cystic Fibrosis Registry in Jordan: Demographic and Clinical Insights
di: Muna Kilani, et al.
Pubblicazione: (2025)

Implementation of Cystic Fibrosis Responsibility, Independence, Self‐Care, Education Program Enhances Cystic Fibrosis Knowledge in Limited Resource Country: Results From a Randomized Controlled Trial
di: Merve Selcuk Balcı, et al.
Pubblicazione: (2025)

Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
di: Laurie P. Murray, et al.
Pubblicazione: (2025)

The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis
di: Leslie Huang, et al.
Pubblicazione: (2025)

Objectively Monitored Sleep in School‐Age Children With Cystic Fibrosis and Their Parents
di: Andrea L. Fidler, et al.
Pubblicazione: (2025)

Impact of Elexacaftor‐Tezacaftor‐Ivacaftor on Quality of Life in Children With Cystic Fibrosis
di: Sara Kümmerli, et al.
Pubblicazione: (2026)

Spirometry Assessments in Children With Sickle Cell Disease in Ghana
di: Baah Agyeiwah Birgit, et al.
Pubblicazione: (2026)

Adherence to Anti‐Staphylococcal Prophylaxis in the First Two Years of Life and Microbiological Outcomes in the First Six Years of Life in Children With Cystic Fibrosis
di: Maryanne Holmes, et al.
Pubblicazione: (2025)

Interrater Reliability of a Modified Bronchoscopy Scoring Tool in Children With Cystic Fibrosis
di: Alexandra Bosetti, et al.
Pubblicazione: (2025)

Increasing Cystic Fibrosis Knowledge of Parents of Children Diagnosed With the Newborn Screening Program
di: Mine Yüksel Kalyoncu, et al.
Pubblicazione: (2025)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase‐1 in Children With Cystic Fibrosis
di: Senthilkumar Sankararaman, et al.
Pubblicazione: (2025)

Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
di: Jeremy P. Tervo, et al.
Pubblicazione: (2025)

Risk Factors and Outcomes of Pulmonary Exacerbations in Infants and Young Children With Cystic Fibrosis
di: Aoife Corcoran, et al.
Pubblicazione: (2025)

Genetic Variants and Clinical Characteristics in the Diagnosis of Children Aged Under 18 Years With Cystic Fibrosis in a Brazilian State
di: Luana da Silva Baptista Arpini, et al.
Pubblicazione: (2025)

Pathophysiology of Cystic Fibrosis Liver Disease
di: Vania L. Kasper, et al.
Pubblicazione: (2024)

Roadmap to Global Cystic Fibrosis Care
di: Samya Z. Nasr, et al.
Pubblicazione: (2025)

Cystic Fibrosis Year in Review 2024
di: Adrienne P. Savant
Pubblicazione: (2025)

Impact of Number of Pharmacies on Dornase Alfa Medication Possession Ratio in Children With Cystic Fibrosis
di: Rebecca S. Pettit, et al.
Pubblicazione: (2025)

Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients (EXOTIC): Protocol of a Randomized, Double‐Blind Clinical Trial
di: Dorottya Gergő, et al.
Pubblicazione: (2026)

Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy Children
di: Lilah D. Melzer, et al.
Pubblicazione: (2025)

Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
di: Rebecca Gallardo, et al.
Pubblicazione: (2026)

Development of a Simplified Arabic Questionnaire of Health‐Related Quality of Life for Children With Cystic Fibrosis
di: Heba A. Ali, et al.
Pubblicazione: (2025)

Microbiological Profile of Airway in Indian Children With Cystic Fibrosis: A Multicenter Prospective Cohort Study
di: Prawin Kumar, et al.
Pubblicazione: (2025)

Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
di: Charissa W. Kam, et al.
Pubblicazione: (2024)

Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis
di: Jordana E. Hoppe, et al.
Pubblicazione: (2025)

Expanding Cystic Fibrosis Registries to the Rest of the World
di: Lutz Naehrlich
Pubblicazione: (2026)

Predictors of Bronchodilator Response on Oscillometry and Spirometry in School‐Age Children With Bronchopulmonary Dysplasia
di: Julia. X. Lee, et al.
Pubblicazione: (2025)

Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis
di: Hillary S. Hayden, et al.
Pubblicazione: (2025)

Commentary on “Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis”
di: Ahmet Kağan Özkaya, et al.
Pubblicazione: (2025)

Real‐World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2–6 With Cystic Fibrosis
di: Adi Dagan, et al.
Pubblicazione: (2026)

Transforming Care in Cystic Fibrosis: The Long‐Term Impact of Quality Improvement Projects on Clinical Outcomes
di: S. Karabulut, et al.
Pubblicazione: (2026)

Disparities in Access to Cystic Fibrosis Therapy Across Countries
di: Bulent Karadag
Pubblicazione: (2026)

Exploring Exercise as Airway Clearance in Cystic Fibrosis: A Qualitative Study From the ExACT‐CF Feasibility Trial
di: Emily Taylor, et al.
Pubblicazione: (2026)

Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
di: Chelsea Flora, et al.
Pubblicazione: (2026)